Ionis Pharmaceuticals Inc. Stock
There is an upward development for Ionis Pharmaceuticals Inc. compared to yesterday, with an increase of €1.42 (2.070%).
With 49 Buy predictions and 1 Sell predictions Ionis Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 76 € shows a slightly positive potential of 8.42% compared to the current price of 70.1 € for Ionis Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Ionis Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 2.070% | 0.689% | 3.240% | 121.976% | 3.149% | 93.807% | 41.545% |
| Ironwood Pharmaceuticals | 1.000% | -14.097% | 46.617% | 10.795% | 46.617% | -62.772% | -54.651% |
| Novocure Ltd | -0.090% | -14.481% | -8.296% | -57.902% | -8.822% | -87.638% | -92.209% |
| Iovance Biotherapeutics Inc. | -1.550% | -4.359% | -7.602% | -62.406% | -7.504% | -70.770% | -93.923% |
Comments
Ionis Pharmaceuticals (NASDAQ:IONS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $95.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at Leerink Partners from $85.00 to $100.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat